Molecular Level Interaction of the Human Acidic Fibroblast Growth Factor with the Antiangiogenic Agent, Inositol Hexaphosphate,

scientific article published on November 23, 2010

Molecular Level Interaction of the Human Acidic Fibroblast Growth Factor with the Antiangiogenic Agent, Inositol Hexaphosphate, is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1021/BI101318M
P953full work available at URLhttps://pubs.acs.org/doi/pdf/10.1021/bi101318m
P698PubMed publication ID21077672
P5875ResearchGate publication ID47793038

P50authorRuey-Hwang ChouQ60566680
P2093author name stringChin Yu
Han-Min Wang
Sepuru K. Mohan
Sriramoju M. Kumar
P2860cites workCancer ResearchQ326097
Journal of Magnetic ResonanceQ3186925
Recovery of mitogenic activity of a growth factor mutant with a nuclear translocation sequence.Q38339080
The PIP2 binding mode of the C2 domains of rabphilin-3AQ38528805
Fibroblast growth factors, proteins with a broad spectrum of biological activities.Q40395069
Anti-angiogenic activity of inositol hexaphosphate (IP6).Q40528072
Inositol phosphates and cell signaling: new views of InsP5 and InsP6.Q40853746
Inositolhexakisphosphate (InsP6): an antagonist of fibroblast growth factor receptor binding and activityQ41432415
Isothermal titration calorimetric study of the association of hen egg lysozyme and the anti-lysozyme antibody HyHEL-5.Q41479629
Nature of the interaction of growth factors with suraminQ42816405
Analysis of putative heparin-binding domains of fibroblast growth factor-1. Using site-directed mutagenesis and peptide analogues.Q42823294
Thermodynamic characterization of the human acidic fibroblast growth factor: evidence for cold denaturationQ43644768
Amplification of the effects of drug resistance mutations by background polymorphisms in HIV-1 protease from African subtypesQ44047107
Inositol-phosphate-induced enhancement of natural killer cell activity correlates with tumor suppressionQ45150380
The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambinQ47682341
Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferationQ54246457
β-Trefoil foldQ56339973
Three-Dimensional Structure of Acidic Fibroblast Growth Factor in Solution: Effects of Binding to a Heparin Functional AnalogQ58622050
Three-dimensional structure and thermodynamics of antigen binding by anti-lysozyme antibodiesQ58670761
PLUSH TACSY: Homonuclear planar TACSY with two-band selective shaped pulses applied to C?,C? transfer and C?,Caromatic correlationsQ60173739
Three-fold structural pattern in the soybean trypsin inhibitor (Kunitz)Q66994216
Carboxyl-terminal structure of basic fibroblast growth factor significantly contributes to its affinity for heparinQ68499278
Thermodynamics of protein association reactions: forces contributing to stabilityQ70820225
Transplacental carcinogenesis by stilbestrolQ95784569
Enhanced-Sensitivity Triple-Resonance Spectroscopy with Minimal H2O SaturationQ108784215
A Gradient-Enhanced HCCH-TOCSY Experiment for Recording Side-Chain 1H and 13C Correlations in H2O Samples of ProteinsQ110644268
Structural basis for FGF receptor dimerization and activationQ22010544
Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerizationQ24290400
Crystallography & NMR System: A New Software Suite for Macromolecular Structure DeterminationQ26778405
Leads for development of new naphthalenesulfonate derivatives with enhanced antiangiogenic activity: crystal structure of acidic fibroblast growth factor in complex with 5-amino-2-naphthalene sulfonateQ27640887
Heparin structure and interactions with basic fibroblast growth factorQ27732601
X-ray crystal structure of human acidic fibroblast growth factorQ27732790
Structure of a heparin-linked biologically active dimer of fibroblast growth factorQ27760195
Solution structure of acidic fibroblast growth factor bound to 1,3, 6-naphthalenetrisulfonate: a minimal model for the anti-tumoral action of suramins and suradistasQ27765171
HADDOCK: a protein-protein docking approach based on biochemical or biophysical informationQ27860814
Protein backbone angle restraints from searching a database for chemical shift and sequence homologyQ27861108
Three-Dimensional Structures of Acidic and Basic Fibroblast Growth FactorsQ28267322
1H-NMR assignment and solution structure of human acidic fibroblast growth factor activated by inositol hexasulfateQ28286658
Angiogenesis in cancer, vascular, rheumatoid and other diseaseQ29547165
HADDOCK versus HADDOCK: new features and performance of HADDOCK2.0 on the CAPRI targetsQ29615981
Angiogenic factorsQ29620582
Antioxidant functions of phytic acidQ34206552
Cancer Inhibition by Inositol Hexaphosphate (IP6) and Inositol: From Laboratory to ClinicQ34275641
Structural basis for activation of fibroblast growth factor signaling by sucrose octasulfateQ34442255
Protection against cancer by dietary IP6 and inositolQ34574206
Heat capacity and entropy changes in processes involving proteinsQ35063139
Applications of calorimetric methods to drug discovery and the study of protein interactionsQ35064543
Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transductionQ35229509
Suramin prevents neovascularisation and tumour growth through blocking of basic fibroblast growth factor activityQ35994206
Oligomerization of acidic fibroblast growth factor is not a prerequisite for its cell proliferation activity.Q36639272
A general enhancement scheme in heteronuclear multidimensional NMR employing pulsed field gradientsQ36732974
The heparin-binding (fibroblast) growth factor family of proteinsQ38286731
Solution NMR structure of a human FGF-1 monomer, activated by a hexasaccharide heparin-analogue.Q38309317
Backbone dynamics of a biologically active human FGF-1 monomer, complexed to a hexasaccharide heparin-analogue, by 15N NMR relaxation methods.Q38310289
Solution structure of human acidic fibroblast growth factor and interaction with heparin-derived hexasaccharideQ38327325
P433issue50
P407language of work or nameEnglishQ1860
P921main subjectangiogenesis inhibitorQ574834
P304page(s)10756-10764
P577publication date2010-11-23
P1433published inBiochemistryQ764876
P1476titleMolecular Level Interaction of the Human Acidic Fibroblast Growth Factor with the Antiangiogenic Agent, Inositol Hexaphosphate,
P478volume49